Cited by 316Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsRenin-Angiotensin System Studies

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.

Konstam, M A, Kronenberg, M W, Rousseau, M F, Udelson, J E, Melin, J, Stewart, D, Dolan, N, Edens, T R, Ahn, S, Kinan, D·1993·Circulation

DOI 10.1161/01.cir.88.5.2277

Open this paper in CoChat — free account

Abstract

BACKGROUND: Patients with heart failure and reduced left ventricular (LV) ejection fraction (EF) manifest progressive LV dilatation, which is prevented by angiotensin converting enzyme (ACE) inhibitors. In patients with asymptomatic LV systolic dysfunction, in whom there is less activation of the renin-angiotensin system, ventricular remodeling might be less rapid and the benefit of ACE inhibitors less discernible. METHODS AND RESULTS: One hundred eight patients enrolled in the Studies of Left Ventricular Dysfunction (SOLVD) Prevention Trial, with left ventricular ejection fraction < or = 0.35 but without clinical heart failure, underwent radionuclide ventriculograms, and 49 underwent left heart catheterizations. Measurements were made before and after double-blinded randomization to enalapril (2.5 to 20 mg/d) or placebo. Repeated-measures analysis of all time points showed significant differences for change in end-diastolic volume (EDV) between enalapril and placebo groups. Significant difference between the enalapril and placebo groups (P < .05) was present for change in EDV at 1 year within the catheterization study and at a mean of 25 months within the radionuclide study. Radionuclide EDV increased in placebo patients (119 +/- 28 to 124 +/- 33 mL/m2, mean +/- SD) and decreased in enalapril patients (120 +/- 25 to 113 +/- 25 mL/m2). Differences between the two groups were significantly less than previously described in patients with symptomatic heart failure (P < .02), with less increase in LV volumes in the placebo group and less decrease in volumes in the enalapril group. CONCLUSIONS: Chronic ACE inhibitor treatment slows or reverses LV dilatation in patients with asymptomatic LV systolic dysfunction. Compared with symptomatic patients, asymptomatic patients manifest a slower rate of spontaneous LV dilatation and less reduction in LV volumes by enalapril.

Integrity signals

Registry

Crossref · 10.1161/01.cir.88.5.2277

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & D, E. B. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,101
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.
McKay, R. G., Pfeffer, M. A., Pasternak, R. C., Markis, J. E., Come, P. C., Nakao, S., Alderman, J. D., Ferguson, J., Safian, R. D., & Grossman, W. (1986) · Circulation · doi:10.1161/01.cir.74.4.693 · Cited by 729
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S. A., & Kinan, D. (1992) · Circulation · doi:10.1161/01.cir.86.2.431 · Cited by 605
Self-citation
Regional Cardiac Dilatation after Acute Myocardial Infarction
Eaton, L. W., Weiss, J. L., Bulkley, B. H., Garrison, J. B., & Weisfeldt, M. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901113000202 · Cited by 549
Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.
FLETCHER, P. J., Pfeffer, J. M., Pfeffer, M. A., & D, E. B. M. (1981) · Circulation Research · doi:10.1161/01.res.49.3.618 · Cited by 363
A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.
Callahan, R. J., FROELICH, J. W., McKusick, K. A., Leppo, J. A., & Strausś, H. W. (1982) · PubMed · Cited by 324

Flagged first, then by citations

Show all 22 references

Sorted by citations

Items 201–300 of 315

Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction
Adachi, Y., Kiyosue, A., Ando, J., Kawahara, T., Kodera, S., Minatsuki, S., Kikuchi, H., Inaba, T., Kiriyama, H., Hirose, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80491-y · Cited by 7
Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling
Basu, S., Yu, H., Murrow, J. R., & Hallow, K. M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011598 · Cited by 7
CardioClasp Changes Left Ventricular Shape Acutely in Enlarged Canine Heart
Kashem, A. M., Santamore, W. P., Hassan, S., Melvin, D. B., Crabbe, D. L., Margulies, K. B., Goldman, B., Llort, F., Krieger, C., & LESNIAK, J. M. (2003) · Journal of Cardiac Surgery · doi:10.1046/j.1540-8191.18.s2.5.x · Cited by 7
Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure
Krzysztofik, J., & Ponikowski, P. P. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1299574 · Cited by 7
Alterations in Ventricular Structure
Anand, I. S., & Florea, V. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10015-4 · Cited by 7
Myocardial Basis for Heart Failure
Owen, A. A., & Spinale, F. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10005-1 · Cited by 7
Angiotensin converting enzyme inhibition improves cerebrovascular control during exercise in male rats with heart failure
Butenas, A. L. E., Colburn, T. D., Baumfalk, D. R., Ade, C. J., Hageman, K. S., Copp, S. W., Poole, D. C., & Musch, T. I. (2021) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103613 · Cited by 7
The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure
IuB, L., Minin, S. M., Efimova, I. Y., Чернов, В. И., Saushkina, Y., Lebedev, D. I., & Popov, S. V. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0696-6 · Cited by 7
Ischemic Mitral Regurgitation: From New Understanding to New Solutions Role of Echocardiography
Levine, R. A., Otsuji, Y., Schwammenthal, E., Sakata, R., & Tei, C. (2006) · Journal of Echocardiography · doi:10.2303/jecho.4.1 · Cited by 7
Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving β-blockade after myocardial infarction
Bonarjee, V., Carstensen, S., Caidahl, K., Nilsen, D. W. T., Edner, M., Lindvall, K., Snapinn, S. M., & Berning, J. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90392-0 · Cited by 7
Assessing LV remodeling in nuclear cardiology
Germano, G., & Slomka, P. J. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0957-1 · Cited by 7
Ultrasound and radiology surrogate endpoints in pharmacological studies
Agewall, S., deGroot, E., Marcos‐Alberca, P., Zamorano, J. L., Barrero, A. A., Badano, L. P., & Filardi, P. P. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.038 · Cited by 6
Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
Opasich, C., Feo, S. D., Cioffi, G., Pulignano, G., Sindaco, D. D., Tarantini, L., Gualco, A., & Patrignani, A. (2005) · PubMed · Cited by 6
Ischemic Mitral Regurgitation
Beeri, R., Otsuji, Y., Schwammenthal, E., & Levine, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5892-2.00016-7 · Cited by 6
Role of neurohormones in ventricular adaptation and failure
Pouleur, H. G. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90621-1 · Cited by 6
Left ventricular volumes, ejection fraction, and plasma proatrial natriuretic factor (1-98) after withdrawal of enalapril treatment initiated early after myocardial infarction. CONSENSUS II Multi-Echo Study Group.
Bonarjee, V., Omland, T., Nilsen, D. W. T., Carstensen, S., Berning, J., Edner, M., & Caidahl, K. (1995) · Heart · doi:10.1136/hrt.73.6.506 · Cited by 6
Late Improvement in Ventricular Performance Following Internal Cardioversion for Persistent Atrial Fibrillation:
Boriani, G., Biffi, M., Rapezzi, C., Ferlito, M., Bronzetti, G., Reggiani, M. L. B., Zannoli, R., & Branzi, A. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.t01-1-00172.x · Cited by 6
Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysis
van de Bovenkamp, A. A., Nassiri, S., Bakermans, A. J., Burchell, G. L., de Man, F. S., van Loon, R. B., & Handoko, M. L. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00544.2024 · Cited by 5
Effect of esaxerenone on ischaemia and reperfusion injury in rat hearts
Yamashita, H., Fujii, M., Bessho, R., & Ishii, Y. (2023) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad405 · Cited by 5
The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study
Karlström, P., Johansson, P., Dahlström, U., Boman, K., & Alehagen, U. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.054 · Cited by 5
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy
Nanas, J. N., Tsagalou, E. P., Nanas, S., Terrovitis, J. V., Tsolakis, E. J., Toumanidis, S., Papazoglou, P., Alexopoulos, G. P., Kanakakis, J., & ANASTASIOU‐NANA, M. I. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.05.010 · Cited by 5
Spirals, paradigms, and the progression of heart failure
Poole-Wilson, P. A. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80002-9 · Cited by 5
A Practical Approach to Hypertension in the 21st Century
Waybill, M. M., & Waybill, P. N. (2003) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000083253.29749.2f · Cited by 5
Prevention and reversal of LV remodeling with neurohormonal inhibitors
Patten, R. D., & Soman, P. (2004) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-004-0033-4 · Cited by 5
Section 5: Management of Asymptomatic Patients With Reduced Left Ventricular Ejection Fraction
Heart Failure Society of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.010 · Cited by 6
Disease Management of Chronic Heart Failure in the Elderly
McDonald, K. (2007) · Disease Management & Health Outcomes · doi:10.2165/00115677-200715060-00002 · Cited by 5
Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study
Rinkūnienė, D., Krivickienė, A., Laukaitienė, J., & Jurkevičius, R. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.051 · Cited by 4
ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study
Atan, N. M. A. S., Hadi, M. F., Teoh, V. W. Y., Danaee, M., & Loch, A. (2023) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484231195019 · Cited by 4
Impact of Clinical Audit on Adherence to the Guidelines Directed Medical Therapy in Patients Admitted with Heart Failure
Shukkoor, A. A., George, N. E., Radhakrishnan, S., Velusamy, S., Kaliappan, T., Gopalan, R., Anandan, P. K., Palanimuthu, R., & Balasubramonian, V. R. (2020) · Current Drug Safety · doi:10.2174/1574886315666200310114528 · Cited by 4
Delapril versus enalapril in patients with congestive heart failure
Dalla‐Volta, S., & The Delapril Heart Failure Study Investigators (1999) · Current Therapeutic Research · doi:10.1016/s0011-393x(99)80023-x · Cited by 4
End points in chronic heart failure clinical trials
Anand, I. S., & Florea, V. G. (2010) · Dialogues in Cardiovascular Medicine · Cited by 4
B-Type Natriuretic Peptide to Assess Cardiac Function in the Critically Ill
McLean, A. S., & Huang, S. (2005) · Springer eBooks · doi:10.1007/0-387-26272-5_15 · Cited by 4
Cardiac Remodeling and Its Prevention
Pfeffer, M. A. (2002) · doi:10.1007/978-1-4615-6490-4_5 · Cited by 4
Surgical Management of Heart Failure
Zeltsman, D., & Acker, M. A. (2003) · doi:10.1002/9780470994757.ch12 · Cited by 4
OPC-8212, a Quinoline Derivative, Counteracts the Reduction in Type III Collagen mRNA due to Lipopolysaccharides in Cultured Rat Cardiac Fibroblasts.
Issei, S. A. N. O., Kusachi, S., Murakami, T., Ninomiya, Y., Oka, T., Nunoyama, H., Kumashiro, H., Iwabu, A., Ueta, J., & Tsuji, T. (2001) · Japanese Heart Journal · doi:10.1536/jhj.42.125 · Cited by 4
Effect of Levosimendan on Ventricular Remodelling in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis
Wang, X., Zhao, X., Wang, X., Cao, L., Lu, B., Wang, Z., Zhang, W., Ti, Y., & Zhong, M. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14714 · Cited by 3
Improving care of chronic heart failure: advances from drugs to devices.
Starling, R. C. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.2.141 · Cited by 3
Diagnosis and treatment strategies for children with myocarditis
Singh, R. K., Yeh, J. C., & Price, J. F. (2016) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2016.08.022 · Cited by 3
Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction
McKelvie, R. S., Benedict, C., & Yusuf, S. (2002) · Wiley eBooks · doi:10.1002/9780470986882.ch45 · Cited by 3
Empfehlungen zur Diagnose und Behandlung der chronischen Herzinsuffizienz
(2002) · Bulletin des Médecins Suisses · doi:10.4414/saez.2002.09042 · Cited by 3
Section 5: Management of Asymptomatic Patients with Reduced Left Ventricular Ejection Fraction
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.014 · Cited by 2
Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction
Bach, R. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00012-6 · Cited by 2
Medical management of mild-to-moderate heart failure before the advent of beta blockers
Abraham, W. T., & Wagoner, L. E. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00386-6 · Cited by 2
Determining the Role of Intravenous Hydration on Hospital Readmissions for Acute Congestive Heart Failure
Sharma, M., Patel, R. K., Krishnamurthy, M., & Snyder, R. (2018) · Clinics and Practice · doi:10.4081/cp.2018.981 · Cited by 2
Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP‑1 polymorphisms with echocardiography parameters: A comparative study
Suciu‐Petrescu, M., Truță, A., Suciu, M. D., Trifa, A. P., Petrescu, D., Roșianu, H., Sabin, O., Popa, D. E., Macarie, A. E., Vesa, Ș. C., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10118 · Cited by 2
Antihypertensives
Daniels, V., & Casey, A. (1999) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30199-2 · Cited by 2
Cardiovascular Pharmacology
Royster, R. L., Groban, L., Grosshans, D. W., Jones, M., & Slaughter, T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1617-7.00010-8 · Cited by 2
Medical and surgical treatment of chronic heart failure
Wu, A. H. (2003) · Current Problems in Cardiology · doi:10.1016/s0146-2806(03)00043-4 · Cited by 2
Neurohormonal Activation and Progression of Heart Failure
Francis, G. S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199806321-00004 · Cited by 2
Structural Remodeling in the Development of Chronic Systolic Heart Failure: Implication for Treatment
Anand, I. S., & Florea, V. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-44577-9_17 · Cited by 1
Evaluation of cardiac remodeling in pediatric chronic kidney disease by cardiovascular magnetic resonance
Song, S., Xie, L., Xu, H., Xu, K., Fu, H., Zhang, L., Hou, R., Tao, Y., & Guo, Y. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04179-1 · Cited by 1
Untargeted metabolic analysis in serum samples reveals metabolic signature in children with congenital heart failure on enalapril therapy
Smeets, N. J. L., van Hoek, I. N., Jans, J. J. M., Dalinghaus, M., Läer, S., Bajčetić, M., Male, C., & de Wildt, S. N. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1530063 · Cited by 1
The ACE2/Ang-(1–7) Pathway in Cardiac Fibroblasts as a Potential Target for Cardiac Remodeling
Cowling, R. T., & Greenberg, B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_30 · Cited by 1
Electrocardiographic QRS Duration Reflects Right Ventricular Remodeling in Patients Undergoing Corrective Surgery for Isolated Tricuspid Regurgitation: A Comparative Study with Cardiac Magnetic Resonance Imaging
Seo, M., Park, E., Kim, H., Lee, W., Kim, Y.-J., Kim, K. H., Kim, K., Sohn, D., Ahn, H., & Park, J. H. (2012) · Clinical Cardiology · doi:10.1002/clc.22030 · Cited by 1
Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction
Man, J. P., Tymchak, W. J., & Jugdutt, B. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3773-6.10013-8 · Cited by 2
Relationships between left ventricular geometry and remodeling in dilated cardiomyopathy
Dziewięcka, E. M., Wiśniowska‐Śmiałek, S., Khachatryan, L., Karabinowska, A., Szymonowicz, M., Podolec, P. S., & Rubiś, P. (2019) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.19.04856-4 · Cited by 1
Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis
Hou, C., Hao, X., Sun, N., Luo, X., Wang, L., Yang, E., Gao, Z., Chen, L., Wang, Z., Cui, Y., et al. (2023) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484231219603 · Cited by 1
Reversibility of Cardiac Remodeling in Hypertensive Patients with Heart Failure
Paini, A., Rosei, C. A., Ciuceis, C. D., Salvetti, M., & Muiesan, M. L. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-39315-0_22 · Cited by 2
Evolving concepts in left ventricular systolic and diastolic remodeling: Implications for therapy
Tang, W. H. W., & Francis, G. S. (2004) · Current Cardiology Reports · doi:10.1007/s11886-004-0024-9 · Cited by 1
Recent Developments in Imaging of Myocardial Angiotensin Receptors
Läutamaki, R., Knuuti, J. M., & Saraste, A. (2013) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-013-9245-x · Cited by 1
Current concepts in the treatment of patients with heart failure
Kimmelstiel, C. D., Udelson, J. E., Smith, J. J., & Konstam, M. A. (1998) · ACC Current Journal Review · doi:10.1016/s1062-1458(98)00045-2 · Cited by 1
Self-citation
Ischemic Mitral RegurgitationPreprint
Aliter, H. (2020) · doi:10.22541/au.158888166.69875316 · Cited by 1
Ventricular Remodeling in Heart Failure
Aquila, I., & Shah, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.10903-2 · Cited by 1
Remodelling of the heart is not a proven clinical concept
Poole-Wilson, P. A. (1997) · Basic Research in Cardiology · doi:10.1007/bf00797214 · Cited by 1
Pathophysiology of Water Metabolism During Critical Illness
Parks, M. H., & Verbalis, J. G. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2584-1_9
Strategies in Surgical Management
Kron, I. L. (2016) · Springer eBooks · doi:10.1007/978-1-4471-4279-9_3
Myocardial metabolism in experimental infarction and heart failure
Råmunddal, T. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Clinical Epidemiology: Principles Revisited in an Approach to Study Heart Failure
Azevedo, A. (2012) · InTech eBooks · doi:10.5772/32074
Ia Directiva Latinoamericana para la evaluación y conducta en la insuficiencia cardíaca descompensada Parte I
Cardíaca, G. D. E. D. I., & de Directivas, D. (2006) · Redalyc (Universidad Autónoma del Estado de México)
Treating Systolic Heart Failure
Rao, V. U., & Teerlink, J. R. (2010) · Wiley eBooks · doi:10.1002/9780470669402.ch13
Neurohormones in Advanced Heart Failure
Francis, G. S. (2000) · Springer eBooks · doi:10.1007/978-4-431-68331-5_1
Myokardiale Protektion und Konditionierung
Unterkofler, J., & Goetzenich, A. (2014) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-014-1095-6
Evidence-Based Management of the Patient with Congestive Heart Failure
Shammas, N. W. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_25
Improvement of Cardiac Function Persists Long Term With Medical Therapy for Left Ventricular Systolic Dysfunction
Chen, D. J., Chang, R., Umakanthan, B., Stoletniy, L. N., & Heywood, J. T. (2007) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248407303782
Role and Optimal Dosing of Angiotensin-Converting Enzyme Inhibitor Therapy
Kazi, D. S., & Deswal, A. M. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2004.10.002
Current management of acute myocardial infarction.
Smith, S. M. (1995) · PubMed
Assessment of left ventricular dysfunction by nuclear cardiology
Melin, J. A., Wijns, W. C., Vanoverschelde, J., & Heyndrickx, G. R. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877323
Self-citation
Cardiac Resynchronisation Therapy in Patients with NYHA Class I–II
Linde, C. M. (2006) · Springer eBooks · doi:10.1007/88-470-0371-7_63
NONINVASIVE MYOCARDIAL ENDOTHELIAL INTERVENTION IN THE PERSISTENCE OF CORONARY STENOSIS: A CONCEPT OF MYOCARDIAL ENDOTHELIAL NITRIC OXIDE ACTIVATOR THROUGH HEART FAILURE RESEARCH ON CLINICAL DEMAND
Yaoita, H., Watanabe, K., Ogawa, K., & Maruyama, Y. (2005) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.51.51
Blockade of Angiotensin II at the AT1 Receptor During Acute Inferior Myocardial Infarction: Assessment by Tei Index
Nearchou, N. S., Tsakiris, A. K., Tsiafoutis, I. N., Lolaka, M. D., Zarcos, I., Flessa, C. D., Kiriakou, K. H., Livaditis, I. G., & Skoufas, P. D. (2004)
Evaluation and management of side effects of breast cancer treatment
Boekhout, A. H. (2011) · Utrecht University Repository (Utrecht University)
Effect of Valsartan on Echocardiographic Ejection Fraction, Brain Natriuretic Peptide and Malondialdehydein Trastuzumab Treated Females with Breast Cancer
Al-sarraf, A. M., Hashim, H. M., Sahib, H. B., Salih, H. N., Al-zubaidy, A. A., Alwan, I. K., & Rabeea, I. S. (2014)
Safety and efficacy of rennin-angiotensin system inhibitors in heart failure with preserved ejection fraction
Singh, M., Shah, T. J., Adigopula, S., Khosla, S., Arora, R., & Jawad, E. (2011) · International journal of collaborative research on internal medicine & public health
Ischemic Mitral Regurgitation
Klautz, R. J. M., & Dion, R. A. E. (2010) · Springer eBooks · doi:10.1007/978-1-84996-426-5_10
Heart failure : biomarker effect and influence on quality of life
Karlström, P. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-124560
Iª Directiva Latinoamericana para la evaluación y conducta en la insuficiencia cardíaca descompensada Parte III
del Comité, M., Bocchi, E. A., Perrone, S. V., Caamaño, A. G., Junior, C. V. S., de Albuquerque, D. C., Almeida, D. R., Bacal, F., Moreira, L. F. P., Moreira, M. D. L. C., et al. (2006)
Associação de variáveis histopatológicas de biópsias endomiocárdicas pré e pós cirúrgicas com os resultados clínicos de pacientes com disfunção ventricular esquerda grave submetidos à revascularização do miocárdio
Wender, O. C. B., & Clausell, N. (2001)
Sociedade Brasileira de Cardiologia Brazilian Society of Cardiology Conselho Editorial Editorial Board
Mesquita, E. T., Junior, C. V. S., de Suplemento, Guimarães, J. I., Liberman, B., Mansur, A. J., Sousa, A. G. M. R., Sposito, A. C., Rassi, A., Lopes, A. A., et al. (2005)
Insuffisance cardiaque : le remodelage inverse
Lamblin, N. (2009) · La Lettre du cardiologue
Antagonism of the Renin-Angiotensin-Aldosterone System in Heart Failure
Konstam, M. A., & Patten, R. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10045-2
Self-citation
Clinical Applications of Renin–Angiotensin System Inhibitors
Burnier, M. (2012) · doi:10.2217/9781780840789
Drugs Blocking the Renin-Angiotensin-Aldosterone System
FRANCIS, G. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-0408-4.50024-x
Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies
Shammas, N. W. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.015
A Historical Overview of Cardiovascular Medicine and Heart Failure
Weaver, C. V., & Garry, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-44577-9_1
Overview of the Therapeutic Use of Angiotensin- Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Mineralocorticoid Receptor Antagonists, and Direct Renin Inhibitors
Mercier, K., Smith, H. D., & Biederman, J. I. (2014)
OBSOLETE: Ventricular Remodeling in Heart Failure
Shah, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.10903-1
Molecular and Cellular Mechanisms for Myocardial Recovery
Topkara, V. K., & Mann, D. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10008-7
Drug–Nutrient Interactions
Litchford, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-30730-1_15
Functional, structural and molecular investigations into experimental type-1 and type-2 diabetes-induced cardiomyopathy
D’Souza, A. (2011) · CLOK (University of Central Lancashire)
Section 7: Heart Failure in Patients With Reduced Ejection Fraction
(2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.016

Authors: Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D.
Affiliations: Tufts University (US)
ORCID: Konstam, M A
Kronenberg, M W
Udelson, J E
Stewart, D
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1993-11
Volume: 88
Issue: 5
Pages: 2277-2283
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.88.5.2277
OpenAlex: W1981884097
Cited by: 316
References: 22
Citations by year: 2026: 3 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 2 · 2021: 7 · 2020: 9 · 2019: 10 · 2018: 7 · 2017: 17 · 2016: 5 · 2015: 3 · 2014: 9 · 2013: 6 · 2012: 10
FWCI: 7.94
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc055010-009)
National Heart, Lung, and Blood Institute (N01-HC-55010)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords: enalapril, ACE inhibitors, left ventricular dilatation, left ventricular systolic dysfunction, asymptomatic heart failure, ventricular remodeling, end-diastolic volume, left ventricular ejection fraction, renin-angiotensin system, heart failure prevention
MeSH terms: Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Blood Volume, Enalapril, Female, Cardiac Catheterization, Heart Diseases, Humans, Male, Middle Aged, Systole, Time Factors, Vasodilation, Radionuclide Ventriculography, Ventricular Function, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks